| 2008 |
IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex; surface plasmon resonance showed IL-17A and IL-17F bind IL-17RC with comparable affinities but bind IL-17RA with different affinities; siRNA knockdown of IL-17RA or IL-17RC abolished heterodimer activity in bronchial epithelial cells. |
siRNA knockdown, surface plasmon resonance (SPR), functional cytokine assay |
Journal of immunology |
High |
18684971
|
| 2008 |
IL-25 (IL-17E)-mediated activities require both IL-17RB and IL-17RA; splenocytes from IL-17RA KO mice failed to produce IL-5 or IL-13 in response to IL-25, and IL-17RA KO mice failed to respond to intranasal IL-25; blocking anti-IL-17RA mAb prevented IL-25 activity in human cells. |
Knockout mouse model, antagonistic antibody blockade, in vitro cytokine assay, in vivo pulmonary inflammation model |
Journal of immunology |
High |
18768888
|
| 2010 |
IL-17RA signaling requires an extended SEFIR domain (termed SEFIR+TILL) beyond the previously defined SEFIR motif for downstream signaling; Act1 recruitment alone is not sufficient for signaling, but TRAF6 ubiquitination correlates tightly with functional receptors; deletion of the CC' loop (not the BB' loop) from IL-17RA abolished Act1-IL-17RA interaction. |
Structure-function mutagenesis, receptor deletion constructs, functional reporter assays, ubiquitination assays |
Journal of Biological Chemistry |
High |
20729198
|
| 2011 |
The CC' loop of the SEFIR domain of IL-17RA is required for Act1 binding; SPR showed a CC' loop-based peptide directly binds IL-17RA; a cell-permeable CC' loop decoy peptide inhibited IL-17- and IL-25-mediated signaling in vitro and pulmonary inflammation in vivo. |
Surface plasmon resonance, deletion mutagenesis, cell-permeable decoy peptide in vitro and in vivo |
Science signaling |
High |
22045852
|
| 2010 |
Both IL-17RA and IL-17RC are required for IL-17A- and IL-17F-induced NF-κB and MAPK (ERK, p38, JNK) activation and IL-6/IL-8/CCL20 secretion in human rheumatoid synoviocytes; siRNA silencing of either receptor nearly abolished IL-6 expression mediated by IL-17A. |
siRNA knockdown, MAPK western blotting, ELISA, microarray |
Annals of the rheumatic diseases |
Medium |
21109515
|
| 2007 |
Both IL-17RA and IL-17RC are required for IL-17A-mediated activation of ERK, p38, JNK, AP-1, and p65 NF-κB in gastric adenocarcinoma cells; siRNA knockdown of either receptor nearly abolished IL-17A-induced c-Jun and p65 activation. |
siRNA knockdown, MAPK western blotting, transcription factor binding assay (TransAM), ELISA |
Cytokine |
Medium |
17644350
|
| 2008 |
Both IL-17RA and IL-17RC are required for IL-17A-induced ELR+ CXC chemokine (CXCL1, CXCL5, CXCL6) expression in synoviocytes; siRNA silencing of either receptor reduced IL-17A-induced IL-6, IL-8, and CCL-20 secretion. |
siRNA knockdown, ELISA, microarray |
Journal of immunology |
Medium |
18097068
|
| 2018 |
RKIP directly interacts with IL-17RA and Act1 to promote formation of the IL-17R-Act1 complex, resulting in enhanced MAPK and NF-κB activation and downstream cytokine production; RKIP deficiency in mice ameliorated EAE symptoms and reduced IL-17R-mediated proinflammatory responses. |
Co-immunoprecipitation, adoptive T cell transfer, KO mouse model, NF-κB/MAPK reporter assays |
EMBO reports |
Medium |
29674348
|
| 2020 |
Crystal structure of the extracellular domain of human IL-17RC in complex with IL-17F revealed that IL-17RC forms a symmetrical 2:1 complex with IL-17F, competing with IL-17RA for cytokine binding; biophysical studies showed IL-17A and IL-17A/F heterodimer also form 2:1 complexes with IL-17RC, suggesting IL-17RA-independent signaling is possible. |
X-ray crystallography, biophysical binding assays (SPR/ITC) |
Immunity |
High |
32187518
|
| 2022 |
IL-17A, IL-17F, and IL-17A/F induce IL-17RA dimerization; crystal structure of the extracellular domains of IL-17RA and IL-17RC in complex with IL-17A revealed a 2:2:2 hexameric signaling assembly; dimerization-defective IL-17RA mutants showed reduced IL-36γ and CXCL1 mRNA induction in human keratinocytes. |
X-ray crystallography, biophysical assays, mutagenesis, functional mRNA expression assay in keratinocytes |
Cell reports |
High |
36260993
|
| 2017 |
Cyanidin specifically binds to an IL-17A binding site within IL-17RA (structure-based identification) and inhibits the IL-17A/IL-17RA interaction; this blocked IL-17A-induced skin hyperplasia and attenuated TH17-driven airway hyperreactivity in mice. |
Structure-based virtual screening, binding assays, in vivo murine models of psoriasis and asthma |
Science signaling |
Medium |
28223414
|
| 2016 |
A 15-residue phage-display-derived peptide (HAP) binds IL-17A and blocks IL-17A/IL-17RA interaction; crystal structure revealed two HAP molecules bind one IL-17A dimer symmetrically with the C-terminal helix directly blocking the IL-17RA binding region of IL-17A. |
Phage display, saturation mutagenesis, X-ray crystallography, primary human cell functional assay |
Scientific reports |
High |
27184415
|
| 2019 |
IL-17A/IL-17RA signaling promotes fatty acid uptake in ovarian cancer cells via the IL-17RA/p-STAT3/FABP4 axis; IL-17RA was required for IL-17A-induced STAT3 phosphorylation and FABP4 upregulation, promoting cellular palmitic acid uptake. |
In vitro cytokine stimulation, Western blotting, IL-17A-deficient mouse orthotopic model, siRNA knockdown |
Cancer immunology, immunotherapy |
Medium |
31802182
|
| 2011 |
IL-17RA is required for CCL2 expression and MMP12 induction in response to cigarette smoke; IL-17RA-/- mice failed to develop emphysema after 6 months of cigarette smoke exposure, establishing IL-17RA signaling as necessary for smoke-induced COPD pathology. |
IL-17RA knockout mouse model, qPCR for CCL2 and MMP12, histological assessment of emphysema |
PloS one |
High |
21647421
|
| 2009 |
IL-17RA signaling is required for neutrophil migration and myeloperoxidase increases in the lung after influenza infection; IL-17RA-/- mice showed reduced oxidized phospholipids and were protected from acute lung injury, but IL-17RA was dispensable for CD8+ T cell recruitment and viral clearance. |
IL-17RA knockout mouse model, flow cytometry, MPO assay, viral clearance assay, lipid oxidation assay |
Journal of immunology |
High |
19783685
|
| 2013 |
IL-17RA is required for optimal localization of follicular Th (TFH) cells in the germinal center light zone; IL-17 signaling upregulates RGS16 in TFH cells to promote TFH-B cell conjugate formation; IL-17RA deficiency in BXD2 mice abrogated autoantibody-forming B cell generation without affecting total TFH numbers. |
IL-17RA knockout mouse (BXD2-Il17ra-/-), adenoviral IL-17R:Fc blockade, immunofluorescence, in vitro conjugate formation assay |
Journal of immunology |
Medium |
23858031
|
| 2022 |
IL-17RA signaling in Lgr5+ intestinal stem cells induces ATOH1 transcription factor expression to promote secretory epithelial cell lineage commitment (Paneth, tuft, goblet, enteroendocrine cells); conditional deletion models showed IL-17RA signaling in ATOH1+ cells was required to regenerate secretory cells following injury; IL-17A stimulation of human intestinal organoids rescued secretory cell differentiation. |
Conditional knockout mouse models, human intestinal organoids, lineage tracing, immunofluorescence |
Immunity |
High |
35081371
|
| 2019 |
IL-17A promotes airway smooth muscle contraction by recruiting Rab35 (via DennD1C GEF) to the IL-17R/Act1 complex, activating PKCα and phosphorylating fascin at Ser39, enabling F-actin/myosin stress fiber formation; cell-type-specific deletion of IL-17R or Act1 in airway smooth muscle cells confirmed direct role. |
Cell-type-specific conditional KO, co-immunoprecipitation, Rab35 knockdown, PKCα inhibitor, contraction assay |
Journal of immunology |
High |
30683702
|
| 2022 |
FTO (a m6A demethylase) suppresses m6A mRNA methylation of IL-17RA, leading to increased IL-17RA expression; knockdown and overexpression of FTO in vitro and in vivo demonstrated FTO as the primary m6A modulator of IL-17RA, and increased IL-17RA promoted chronic hepatic inflammation. |
MeRIP-seq, FTO knockdown/overexpression, murine NAFLD/liver injury models, Western blotting |
Frontiers in oncology |
Medium |
36172147
|
| 2013 |
A soluble isoform of human IL-17RA is generated by alternative splicing that removes exon 11 encoding the transmembrane domain; RT-PCR confirmed this variant in multiple human tissues and the secreted protein was detected in culture media by Western blotting. |
RT-PCR, Western blotting of conditioned media |
Cytokine |
Medium |
24084331
|
| 2019 |
IL-17RA signaling in intestinal epithelial cells regulates microbial composition and constrains translocation of TLR9 ligands (CpG DNA); intestinal epithelium-specific IL-17RA deletion caused microbiome dysbiosis, increased CpG DNA translocation driving hepatic IL-18 production, and exacerbated immune-driven hepatitis. |
Intestinal epithelium-specific IL-17RA conditional KO mouse, 16S microbiome sequencing, hepatitis model, cytokine measurement |
Cell reports |
High |
31747600
|
| 2017 |
IL-17 signaling in fibroblasts requires IL-17RA/STAT3 axis to induce SHP-2, Cyr61, IL-23, GM-CSF and RANKL expression in rheumatoid arthritis fibroblast-like synoviocytes; siRNA knockdown of IL-17RA reversed IL-17-induced RANKL expression and osteoclastogenic potential. |
siRNA knockdown, STAT3 inhibitor, co-culture osteoclastogenesis assay, Western blotting |
Molecular immunology |
Medium |
28898718
|
| 2018 |
IL-17RA/Act1 signaling is required for IL-17R-induced lung immunity against Klebsiella; conditional deletion showed IL-17R signaling specifically in fibroblasts is required for lung-specific protective immunity (not systemic antibody-mediated protection) in a mucosal vaccine model. |
Cell-type-specific conditional IL-17R KO mouse, adoptive transfer, mucosal vaccine model, bacterial challenge |
Science immunology |
Medium |
34516780
|
| 2019 |
IL-17RA signaling in non-hematopoietic cells controls CXCL-1 and CXCL-5 production to recruit neutrophils to the lung during the adaptive immune response to mycobacteria; CXCL-1 and CXCL-5 instillation reconstituted neutrophil recruitment in IL-17RA-/- mice. |
IL-17RA KO mouse, bone marrow transplantation, cytokine instillation rescue experiment, flow cytometry |
PloS one |
Medium |
26871571
|
| 2024 |
Gingerenone A directly binds IL-17RA protein (confirmed by pull-down and SPR) and inhibits IL-17RA/Act1-mediated downstream signaling; lentivirus-mediated IL-17RA/Act1 knockdown impaired GA's protective effects against DSS-induced intestinal inflammation. |
Pull-down assay, surface plasmon resonance, molecular dynamics simulation, lentiviral knockdown, in vivo colitis model |
Advanced science |
Medium |
38639442
|
| 2005 |
IL-17R (IL-17RA) is expressed on human airway smooth muscle (ASM) cells; IL-17 induces CXCL-8 production from ASM cells via a transcriptional mechanism dependent on NF-κB and AP-1 binding sites in the CXCL-8 promoter. |
Immunostaining, surface receptor detection, transcriptional inhibitor (actinomycin D), promoter reporter assay with site-directed mutation, neutralizing antibody |
Clinical immunology |
Medium |
15893694
|
| 2016 |
Complete autosomal recessive IL-17RA deficiency in 21 patients abolished cellular responses to IL-17A/F homodimers and heterodimers in fibroblasts and to IL-17E/IL-25 in leukocytes; alleles creating premature stop codons upstream of the transmembrane domain prevented surface receptor expression, while those downstream or the missense D387N allele permitted surface expression but all abolished signaling. |
Patient genetic analysis, surface receptor expression by flow cytometry, functional IL-17 response assays in fibroblasts and leukocytes |
PNAS |
High |
27930337
|
| 2019 |
IL-17A-induced fibrogenic response in lung fibroblasts is mediated through NF-κB signaling and requires JAK2 (but not JAK1/JAK3) downstream of IL-17RA; siRNA silencing of IL-17RA attenuated ECM production, myofibroblast transdifferentiation, and cell proliferation in response to IL-17A. |
siRNA knockdown, selective JAK inhibitors (AZD1480 vs. tofacitinib), Western blotting, proliferation and ECM assays |
American journal of physiology. Lung cellular and molecular physiology |
Medium |
30604628
|
| 2019 |
IL-17RA signaling in Trypanosoma cruzi-infected mice is intrinsically required in CD8+ T cells for survival and effector function; IL-17A in vitro downregulated pro-apoptotic BAD and promoted activated CD8+ T cell survival; IL-17RA-deficient T. cruzi-specific CD8+ T cells showed increased apoptosis and dysfunction. |
IL-17RA KO mouse, adoptive transfer of IL-17RA-/- vs. WT T cells, in vitro recombinant IL-17 treatment, transcriptomic profiling, PD-L1 blockade |
Frontiers in immunology |
Medium |
30364284
|
| 2025 |
IL-17RA in intestinal epithelial cells (IECs) suppresses EMT by constraining EGFR expression and Src activation; IL-17RA in macrophages is required for Syk activation upon dectin-1 engagement with fungi, and for IL-18 release and CD8+ T cell anti-tumor immunity; these represent two distinct tumor-suppressive IL-17RA mechanisms in colorectal cancer. |
Cell-type-specific conditional KO (IEC and macrophage), tumor models, Syk activation assay, immune cell profiling |
Immunity |
High |
40023157
|
| 2024 |
TCF4 negatively regulates IL-17C; IL-17C stimulation of keratinocytes decreases TCF4 and increases NFKBIZ and ZC3H12A in an IL-17RA/IL-17RE-dependent manner, creating an autocrine inflammatory feedback loop; genetic elimination of Il17ra and Il17re reversed the loop in a murine dermatitis model. |
siRNA knockdown, conditional KO mouse (KC-Tie2), promoter analysis, gene expression profiling |
JCI insight |
Medium |
38470486
|
| 2018 |
IL-17A/IL-17RA signaling promotes NSCLC cell migration and invasion via the p38 MAPK pathway; IL-17RA overexpression increased p38 phosphorylation and MMP-2/MMP-9 expression; p38 MAPK inhibitor SB203580 suppressed migration and invasion; MMP-2 and MMP-9 are downstream of IL-17RA/p38. |
IL-17RA overexpression, p38 MAPK inhibitor, wound healing/Transwell invasion assays, Western blotting |
Molecular and cellular biochemistry |
Medium |
30564960
|
| 2021 |
Conditional deletion of IL-17RA in osteoclast precursors (LysM-Cre) increased trabecular bone mass and decreased osteoclast number in vivo; in vitro osteoclast formation was reduced, associated with lower abundance of osteoclast precursors. |
Conditional KO mouse (LysM-Cre), micro-CT, histomorphometry, in vitro osteoclastogenesis assay |
Bone |
Medium |
34973492
|
| 2018 |
IL-17RA expression in mesenchymal stem cells (MSCs) is required for their immunosuppressive function; IL-17RA-/- MSCs showed reduced VCAM1, ICAM1, and PD-L1 expression, could not suppress Th17 proliferation, and failed to reduce EAE severity or generate regulatory T cells in vivo. |
IL-17RA KO MSC transplantation, EAE model, flow cytometry, in vitro suppression assay |
Frontiers in immunology |
Medium |
29760692
|
| 2018 |
IL-17RA signaling in hepatocytes regulates IL-6 production by non-parenchymal cell recruitment, which in turn triggers hepatocyte proliferation; IL-17RA-/- mice showed delayed early-gene expression and delayed G1/S phase transition after partial hepatectomy. |
IL-17RA KO mouse, partial hepatectomy model, gene expression analysis, cell cycle analysis |
Cell cycle |
Medium |
30395772
|
| 2011 |
IL-17RA PLAD (pre-ligand assembly domain) mediates receptor-chain associations essential for signaling; lentiviral IL-17RA PLAD-Ig expression in spontaneously hypertensive rats reduced collagen deposition, MMP-2/9 expression, and TIMP-1/2 levels, improving diastolic cardiac function. |
Lentiviral PLAD-Ig overexpression in vivo, echocardiography, immunoblotting for ECM proteins |
Experimental and molecular pathology |
Low |
21530504
|
| 2019 |
IL-17B uses IL-17RA and IL-17RB receptor subunits to induce type 2 cytokine secretion from human innate type 2 lymphocytes, NKT, and CD4+CRTH2+ Th2 cells; this activity was dependent on both IL-17RA and IL-17RB. |
Receptor blocking antibodies, primary human lymphocyte functional assays, cytokine measurement |
Journal of immunology |
Medium |
30770417
|
| 2019 |
IL-17C signals through the IL-17RA/IL-17RE receptor heterodimer in oral epithelial cells to stimulate production of TNF-α; IL-17C mRNA was expressed in cultured human oral keratinocytes that also expressed IL-17RA and IL-17RE; neutralizing IL-17C or IL-17R antibodies attenuated these responses. |
qRT-PCR, IL-17C stimulation assay, neutralizing antibody blockade, immunohistochemistry |
Journal of oral pathology & medicine |
Low |
23834281
|
| 2012 |
The IL-17A/IL-17RA axis promotes aortic arch inflammation during atherosclerosis by inducing TNFα and CXCL2 and accelerating neutrophil/monocyte recruitment; IL-17RA supports monocyte adherence to explanted aortas; adoptively transferred monocytes and neutrophils showed impaired homing to IL-17RA-deficient aortas. |
Il17ra-/- Apoe-/- mouse model, flow cytometry, ex vivo adhesion assay, short-term homing experiments with adoptive transfer |
Circulation research |
High |
22302786
|
| 2012 |
IL-17RA signaling is required for CXCL1/CXCL2-dependent neutrophil recruitment during T. cruzi infection; recruited neutrophils secrete IL-10 and suppress T cell proliferation and IFN-γ production in an IL-10-dependent manner; adoptive transfer of WT neutrophils restored this suppressive phenotype and improved survival in IL-17RA KO mice. |
IL-17RA KO mouse, neutrophil depletion (anti-Ly6G), adoptive transfer, in vitro suppression assay |
PLoS pathogens |
High |
22577359
|